IN WHICH R1 IS SELECTED FROM THE GROUP CONSISTING OF HYDROGEN; ALKYL; CYCLOALKYL; AND HETEROCYCLOALKYL, R2 IS A LOWER ALKYL GROUP, R3 IS SELECTED FROM THE GROUP CONSISTING OF HYDROGEN; ALKYL; ARYLOXYALKYL; AND AN ALKALI METAL OR AN ALKALINE EARTH METAL ATOM, R4 IS ALKYLENE SUCH AS METHYLENE, ETHYLENE AND TRIMETHYLENE AND R5 IS SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND ETHINYL, AND AMINE SALTS OF THE ABOVE COMPOUNDS OF THE FORMULA I IN WHICH R3 IS HYDROGEN; AND METHODS FOR THEIR PREPARATION AS WELL AS PHARMACEUTICAL COMPOSITIONS COMPRISING THE PRESENT STEROID COMPOUDS AS AN ACTIVE INGREDIENT.
Abstract:
The invention provides novel compounds of the formula:
AND SALTS THEREOF, IN WHICH R1 is n-butyl, cycloalkyl having five to eight ring carbon atoms, cyclohexenyl, 4methylcyclohexyl, 4,4-dimethylcyclohexyl, 4-methoxycyclohexyl, 2,5-endomethylenecyclohexyl or endoethylenecyclohexyl, R2 is hydrogen or methoxy, methyl, bromine or chlorine in position four or in position five, R3 is methyl or hydrogen, R4 and R5 are each hydrogen or methyl but not both methyl at the same time, or R4 and R5 may together form a bond completing a benzo(b)furan ring system. These compounds are useful in the oral treatment of maturityonset diabetis mellitus.
Abstract:
This invention is concerned with novel and pharmaceutically active indole derivatives having the structure:
AND THE SALTS THEREOF WITH PHYSIOLOGICALLY ACCEPTABLE ACIDS, IN WHICH EACH OF X and Y is selected from the group consisting of hydrogen, chlorine, lower alkyl having 1 - 3 carbon atoms and lower alkoxy having 1 - 3 carbon atoms, R1 is selected from the group consisting of hydrogen, lower alkyl having 1 - 4 carbon atoms and benzyl, R2 is selected from the group consisting of hydrogen, lower alkyl having 1 - 4 carbon atoms, benzyl and phenyl, R3 represents lower alkyl having 1 - 3 carbon atoms, or the two groups R3 form together with the attached nitrogen atom a pyrrolidine or a piperidine ring, and A is an alkylene chain having 2 or 3 carbon atoms.
Abstract:
Novel and therapeutically useful steroid compounds of the estrane, androstane, pregnane or 19-norpregnane series and having the partial ring A configuration: AS WELL AS PROCESSES FOR THE PREPARATION OF THESE STEROID COMPOUNDS.